GH (Guardant Health) Treasury Stock: $0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GH Guardant Health Inc GH
65 GF Score
Price $159.84
GF Value $65.16
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Guardant Health Treasury Stock?

Guardant Health GH +0.57% 65 Treasury Stock is $0 Mil as of Jun. 2026. GuruFocus rates GH with a GF Score™ of 65/100 and a GF Value™ of $65.16 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. Guardant Health's treasury stock for the quarter that ended in Jun. 2026 was $0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Guardant Health Treasury Stock Historical Data

* Premium members only.

The historical data trend for Guardant Health's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health Treasury Stock Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Guardant Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.01 -45.01 0.00 0.00 0.00
GH
65GF Score
Guardant Health Inc GH
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of $0 Mil mean?
Guardant Health (GH) has a Treasury Stock of $0 Mil as of Jun. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Guardant Health and its competitors.
Is Guardant Health's Treasury Stock too high?
Guardant Health's current Treasury Stock is $0 Mil. Overall, Guardant Health has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Treasury Stock compare to MEDP and LH?
Guardant Health's Treasury Stock of $0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Medical Diagnostics & Research company?
A good Treasury Stock depends on the Medical Diagnostics & Research industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Guardant Health and its competitors. Guardant Health's current Treasury Stock is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Based on GuruFocus' analysis, Guardant Health (GH) is currently considered Significantly Overvalued. The stock's GF Value™ is $65.16, compared to a current price of $159.84 — trading 145.3% above its estimated fair value. The current Treasury Stock is $0 Mil. Guardant Health's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Guardant Health (GH), the current Treasury Stock is $0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of $159.84 is trading 145.3% above its estimated GF Value™ of $65.16. GuruFocus considers Guardant Health to be Significantly Overvalued.

Key valuation signals for GH:

  • Treasury Stock: $0 Mil
  • GF Value™: $65.16 vs. price of $159.84 (145.3% above fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guardant Health Business Description

Other Exchanges 1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
65GF Score

Get the complete analysis for GH

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$159.84
Price
$65.16
GF Value